USPTO serial 79035452
Serial No. 79035452
Reviewed by CopyMark Law Group
Reg. 3496121Status 404
- Filing date
- Status date
- Registration date
- Sep 2, 2008
- Examiner
- MIDDLETON, BERNICE L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with Serial No. 79035452?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in industry, science and photography; chemical preparations used in agriculture, horticulture and forestry, namely, chemical preparations for the treatment of seeds; unprocessed artificial resins, unprocessed plastics, manures, fire extinguishing compositions, soldering preparations, namely, soldering chemicals; chemical products for preserving foodstuffs; tanning agents for use in the manufacture of leather; adhesives for industrial purposes; acids, namely, acetic acids, amino acids for laboratory use, formic acid; chemical additives for use in the manufacture of food, pharmaceuticals, cosmetics; alkalies, alkaloids, namely, chemical compounds containing nitrogen; artificial sweeteners; bacteriological preparations, namely, chemical-based bacteriological preparations for use in scientific and medical research; adhesive preparations for use in the manufacture of surgical bandages; biological preparations, namely, chemical-based biological preparations for non-medical use and biological tissue, namely, blood, stem cells, umbilical cords and placentas for use in scientific and medical research; bleaching chemicals, namely, chlorine, calcium hypochlorite, sodium hypochlorite; carbon and preparations thereof, namely, calcium carbonate, composite carbon epoxy resins, carbon disulphide, carbon fluorochloride, carbon tetrachloride; catalysts for chemical and biochemical processes, chemical preparations for scientific purposes, chemical reagents for non-medical purposes, chemical substances for analyses in laboratories; chlorides and chlorates, namely, allyl chloride, aluminium chloride, ammonium chloride, barium chloride, benzyl chloride, bismuth chloride, cacodyl chloride, calcium chloride, cerium chloride, chromium chloride, ethyl chloride, gold chloride, hydrogen chloride, iron chloride, magnesium chloride, mercuric chloride, metal chlorides, silver chloride, sodium chloride, tin chloride, sodium chlorates; cultures of micro organisms for use in medical research; dehydrating preparations, namely, metallic oxides; diagnostic preparations for scientific or research use, ferments for chemical purposes not for medical or veterinary use; filtering materials, namely, chemical preparations in the nature of filtering materials in the biotechnology and biopharmaceutical industries; liquefying chemicals, namely, ethylene glycol, ethylene carbonate, polyethylene glycol; preparations of micro organisms, namely, microorganisms for the degradation of toxins other than for medical use, microorganisms for use in stimulation of plant growth, mixtures of microorganisms and chemicals for increasing the nutritional value of animal fodder other than for veterinary use, microorganisms for sterilizing or fertilizing compost; nitrates, namely, aluminium, barium, lead nitrate; preservatives, namely, chemical preservatives for use in the manufacture of pharmaceuticals; food preservative compositions; purification preparations, namely, chemicals for use in the purification of proteins for in vitro use; salts, namely, salt neutralizing chemical for pharmaceuticals, halogen acid salts, magnesium salts, metallates, salts from rare earth metals, salt for water softening; waterproofing chemical compositions; chemical products for use in the manufacture of pharmaceuticals; compositions, agents, and extended release formulations for use in the manufacture of medicinal products, namely, wetting agents | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceuticals for use in the treatment of influenza, HIV, hepatitis C, hepatitis B, mosquito borne diseases, tuberculosis, rheumatoid arthritis, rotavirus, blood disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, diabetes, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, inflammation and inflammatory disorders, musculoskeletal disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and disorders, sexual dysfunction, urological disorders, viral, protozoa and bacterial disorders, diseases and illnesses; veterinary preparations, namely, amino acids for veterinary purposes, anti-infective products for veterinary use, bacterial preparations for veterinary purposes, biochemical preparations for veterinary use, blood substitute for veterinary use, veterinary vaccines, pain relief medication for veterinary use, veterinary preparations for the treatment of intestinal bacteria, veterinary parasiticides for livestock use; sanitary sterilizing preparations; dietetic foods for medical use; plasters for medical use; materials for dressings, namely, gauze, bandages; dental wax; disinfectants for medical instruments and sanitary purposes; fungicides; herbicides; preparations for destroying vermin; medications, namely, medicated shampoo, allergy medication, acne medications, burn relief medication, diarrhea medication, pain relief medication, medications for use in the treatment of influenza, HIV, hepatitis C, hepatitis B, mosquito borne diseases, tuberculosis, rheumatoid arthritis, rotavirus, blood disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, diabetes, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, inflammation and inflammatory disorders, musculoskeletal disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and disorders, sexual dysfunction, urological disorders, viral, protozoa and bacterial disorders, diseases and illnesses; nutritional substances in the nature of capsules containing glucosamine and chondroitin and nutritional supplements, vitamins, mineral supplements, and nutritional supplements, namely, glucosamine and chondroitin; nutraceuticals for use as a dietary supplement; nutritional supplements; nutritional substances, namely, intravenous fluids used for nutrition; food supplements for medical purposes, dietetic beverages and dietetic foods for medical use; additives to fodder for medical purposes; multivitamin tablets; bacteriological preparations for medical or veterinary purposes; biological preparations and diagnostic preparations for medical use; chemicals for use in the manufacture of pharmaceuticals, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; extended release formulations of human and veterinary medicinal products, namely, acetaminophen, allergy relief medication; compositions and agents being human and veterinary medicinal products, namely, anti-arthritic compositions, diagnostic agents for medical purposes, gastrointestinal cleaning agents, glaucoma agents, lipid lowering agents, tumor suppressing agents, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; rapidly dissolving formulations of human and veterinary medicinal products, namely, ribavirin, dihydroergotamine, ibuprofen, metoclopramide formulations; drugs provided in a delivery and release system for use in the treatment of influenza, HIV, hepatitis C, hepatitis B, mosquito borne diseases, tuberculosis, rheumatoid arthritis, rotavirus, blood disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, diabetes, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, inflammation and inflammatory disorders, musculoskeletal disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and disorders, sexual dysfunction, urological disorders, viral, protozoa and bacterial disorders, diseases and illnesses; extended release pharmaceuticals and rapidly dissolving pharmaceuticals for use in the treatment of influenza, HIV, hepatitis C, hepatitis B, mosquito borne diseases, tuberculosis, rheumatoid arthritis, rotavirus, blood disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, diabetes, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, inflammation and inflammatory disorders, musculoskeletal disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and disorders, sexual dysfunction, urological disorders, viral, protozoa and bacterial disorders, diseases and illnesses; vaccines | SECTION 71 - CANCELLED | — |
| 009 | Communications, photographic, measuring, signaling, checking, scientific, optical, nautical, life-saving and surveying apparatus and instruments, namely, CD-ROM drives, automated microscope and operating software sold as a unit for use in laboratory operations, photographic cameras, video cameras, motion picture cameras, glass tubes for scientific purposes, glassware for scientific experiments in laboratories, plates or glass slides that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use; clinical laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; consumer domestic electrical and electronic apparatus and instruments, namely, battery chargers, camcorders, cameras, cassette players, compact disc players, pre-recorded compact discs featuring scientific instruction, medical research, biological research, chemical analysis, chemical research; computers, computer printers, disk drives for computers, pre-recorded floppy discs featuring scientific instruction, medical research, biological research, chemical analysis, chemical research; headphones, loud speakers, modems, computer monitors, computer mouse, personal stereos, pocket calculators, mobile phones, radios, record players, scanners, stereos, tape recorders, televisions, video players, pre-recorded video cassettes featuring scientific instruction, medical research, biological research, chemical analysis, chemical research; VDUs being computer display monitors, pre-recorded DVDs featuring scientific instruction, medical research, biological research, chemical analysis, chemical research; DVD players; computer database management software for use in the fields of medicine, biochemistry, and chemistry; computer software for use in database management, use as a spreadsheet, word processing; computer software for scientific analysis of genetic sequences; communications software for connecting computer network users; computer software for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data; computer software for the collection, editing, organizing, modifying, transmission, storage and sharing of data and information; computer software for pulmonary, cardiovascular and edema analysis for use in small animal research studies; computer software for interpretation of neuro and brain scans provided by diagnostic imaging equipment; computer hardware and firmware; computer games software; apparatus for recording, reproducing, carrying, storing, processing, manipulating, transmitting, broadcasting and retrieving publications, text, signals, software, information, data, code, sounds and images; instruments and media for recording, reproducing, carrying, storing, processing, manipulating, transmitting, broadcasting and retrieving publications, text, signals, software, information, data, code, sounds and images, namely, computers, computer central processing units, computer hardware, data processors, computer disc drives, CD-ROM drives and DVD drives; audio and video recordings featuring scientific instruction, medical research, biological research, chemical analysis, chemical research; downloadable short educational and training communications in the form of audio recordings, video recordings, electronic music files, electronic sound files, electronic images, electronic text, electronic publications in the nature of newsletters and news bulletins, digital signals, electronic information and data in the form of text files and multimedia files containing artwork, text, audio, video, games, and Internet Web links, downloadable computer game software, downloadable audio files, video files, MP3 recordings, downloadable audio and video files for web casting and pod casting, audio books, text files, emails, written documents, audio material, video material and computer games all in the field of medical research, biological research, chemical analysis, chemical research provided via telecommunications networks, by online delivery and by way of the Internet and the world wide web; sound and video recording and playback machines; coin freed apparatus, namely, coin changers, coin counting or sorting machines, slot machines; televisions and television games apparatus and instruments, namely, televisions sets, video game cartridges, video game cassettes, video game discs, video game joysticks, video game programs, game software and video game controllers; exposed photographic and cinematographic films prepared for exhibition featuring instruction, medical research, biological research, chemical analysis, chemical research; photographic slide transparencies; downloadable publications, namely, electronic publications in the nature of audio books, text files, emails or written documents, all featuring medical research, biological research, chemical analysis, chemical research; downloadable audio files, downloadable video files, downloadable MP3 recordings, and downloadable audio and video files for web casting and pod casting, all featuring medical research, biological research, chemical analysis, chemical research; educational and teaching apparatus and instruments, namely, educational software, CD-ROMs and DVDs featuring instruction in the field of medical research, biological research, chemical analysis, chemical research; electronic, magnetic and optical membership cards; sunglasses and sun visors; mouse mats; protective clothing and protective headgear, namely, protective goggles and masks; data processing equipment, namely, data processors, central processing units for processing data; replacement parts and replacement fittings for all the aforesaid goods | SECTION 71 - CANCELLED | — |
| 038 | Provision of access to a computer database; providing access to computers, namely, providing access to a global computer information network | SECTION 71 - CANCELLED | — |
| 040 | Manufacture of pharmaceuticals for others, development and manufacture of general product lines in the field of pharmaceuticals to the order and specification of others; manufacture of pharmaceutical goods for others; consultation in the field of manufacturing pharmaceuticals; custom and contract manufacture of pharmaceuticals for others; custom development of pharmaceutical products; development of pharmaceutical compounds; development of general pharmaceutical product lines in the field of pharmaceuticals to the order and specification of others; custom development of pharmaceuticals; consultation in the field of developing pharmaceuticals; providing information and advice relating to the foregoing | SECTION 71 - CANCELLED | — |
| 042 | Scientific and technological services and research and design relating thereto, namely, medical research, biological research, chemical analysis, chemical research; design services, namely, design of pharmaceuticals, research services in the fields of medicine, biology, chemical analysis; medical research services, bacteriological research, biological research, chemical analysis, chemical research; computer software and hardware design and programming services, engineering, material testing, research in the field of physics; technical project studies in the fields of medical research, biological research, chemical analysis, chemical research; research services in the fields of medicine, biology, chemical analysis; and development services, namely, development of pharmaceuticals and vaccines; development of pharmaceutical formulations, clinical scientific evaluation of pharmaceuticals, legal services, namely, regulatory registration of pharmaceuticals and official licensing of pharmaceuticals compounds; research and development for others in the field of pharmaceuticals; professional, technical and scientific consulting services, namely, consulting in the medical, biological and chemical fields; preparation of reports, namely, medical, biological and chemical reports; design, development, analysis, testing, assessment, consultancy and advice in the field of chemical and medical products and services, legal services, namely, official regulatory assistance and advice in the fields of chemical, sanitary, food, beverage, nutritional, naturopathic, pharmaceutical, medical, veterinary and healthcare products and services, legal services; legal services, namely, intellectual property services; management, consultancy, development, advice, analysis, design, evaluation, and programming and licensing of computer software, firmware, hardware; rental of electric and electronic goods, namely, computers, computer hardware, laboratory apparatus and instruments and measuring apparatus, medical, biomedical and biochemical scientific apparatus; consultancy advice relating to the evaluation, choosing and implementation of computer software, firmware, hardware, information technology and of data processing systems, recovery of computer data; provision of research and development facilities in the nature of medical laboratories; advice and consultation relating to computer software and hardware and information technology systems; providing information and advice relating to the foregoing; including the provision of the aforesaid services by online means, by way of the Internet and/or communication networks | SECTION 71 - CANCELLED | — |
| 044 | Medical services, veterinary services, hygiene services for human beings, namely, dental hygienist services; medical clinics, convalescent home services, dentistry, healthcare services, nursing homes, midwife services, opticians services, physiotherapy services, psychology services, namely, psychotherapy services, psychological counseling services, psychological testing services, blood bank services, agricultural services, namely, agricultural advice, spreading of fertilizers and other agricultural chemicals; horticultural services; forestry services, namely, providing advice pertaining to pest control for forestry; hospice, hospital, medical assistance, nursing care services, providing pharmaceutical advice, and rest home services; surgery, consultancy and advice in the fields of sanitary products and services in the nature of medical sanitary sterilizing preparations, nutritional products and services in the nature of dietetic foods and beverages adapted for medical use, nutritional supplements, intravenous fluids used for nutrition, food supplements for medical purposes, naturopathic products and services in the nature of nutritional supplements, vitamins, mineral supplements, multivitamin tablets, allopathic products and services for use in connection with allopathic remedies, pharmaceutical products and services for use in connection with the treatment of influenza, HIV, hepatitis C, hepatitis B, mosquito borne diseases, tuberculosis, rheumatoid arthritis, rotavirus, blood disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, diabetes, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, inflammation and inflammatory disorders, musculoskeletal disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and disorders, sexual dysfunction, urological disorders, viral, protozoa and bacterial disorders, diseases and illnesses, medical and healthcare products and services in the nature of vaccines, medicated shampoo, allergy medication, acne medications, burn relief medication, diarrhea medication, pain relief medication; information and advisory services relating to the foregoing; including the provision of such services via the Internet, by online means and/or by communications networks | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PepTcell Limited
- Other trademarks owned by PepTcell Limited
- Other trademarks owned by PepTcell Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 038
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 044
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 19, 2017 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| May 19, 2017 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Oct 21, 2016 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Feb 16, 2016 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Feb 16, 2016 | INPC | INVALIDATION PROCESSED | — |
| Dec 3, 2015 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Apr 3, 2015 | C71T | CANCELLED SECTION 71 | — |
| Dec 30, 2012 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 5, 2009 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 5, 2009 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 2, 2008 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 2, 2008 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 17, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 28, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| May 12, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 9, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 9, 2008 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 9, 2008 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 9, 2008 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 9, 2008 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 8, 2008 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| May 5, 2008 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Apr 21, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 18, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 17, 2008 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 17, 2008 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 17, 2008 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 17, 2008 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 18, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 17, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 17, 2008 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Feb 25, 2008 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Feb 25, 2008 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 25, 2008 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 14, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 14, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 14, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 19, 2007 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 19, 2007 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 19, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 14, 2007 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 27, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 27, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 26, 2007 | ALIE | ASSIGNED TO LIE | — |
| Oct 18, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 17, 2007 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 26, 2007 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 26, 2007 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 26, 2007 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 25, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 5, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 5, 2007 | NWAP | NEW APPLICATION ENTERED | — |
| Apr 5, 2007 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |